Contents

Current Drug Therapy, Volume 3 - Number 3

Current Advances in the Development of Anticancer Drugs Targeting Tyrosine Kinases of the Src Family

, 3(3): 158 - 176

Silvia Schenone, Samantha Zanoli, Chiara Brullo, Emmanuele Crespan and Giovanni Maga


DOI: 10.2174/157488508785747862




New Targets for Therapy in Polyglutamine (polyQ) Expansion Diseases

, 3(3): 177 - 189

Lorena Perrone and Mariarosa A.B. Melone


DOI: 10.2174/157488508785747835




Whos Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pylori

, 3(3): 190 - 203

Kathleen R. Jones, Jeong-Heon Cha and D. Scott Merrell


DOI: 10.2174/157488508785747899




Therapy and Further Development of Anti-Leishmanial Drugs

, 3(3): 204 - 208

Joana A. Pinto da Costa Tavares, Ali Ouaissi and Anabela Cordeiro-da-Silva


DOI: 10.2174/157488508785747871




Nanogel Engineered Polymeric Micelles for Drug Delivery

, 3(3): 209 - 217

Supriya Shidhaye, Vishwanath Lotlikar, Sheetal Malke and Vilasrao Kadam


DOI: 10.2174/157488508785747880




Sphingomyelinase Inhibition Suggests a Possible New Strategy for the Treatment of Inflammatory Bowel Disease

, 3(3): 218 - 225

Shinji Soeda, Akira Sakata, Takashi Ochiai, Kazuya Yasuda, Yukako Kuramoto, Hiroshi Shimeno, Akihisa Toda, Reiko Eyanagi, Sadao Hikishima, Tsutomu Yokomastu and Shirashi Shibuya


DOI: 10.2174/157488508785747853




Genetically Modified Hepatitis B Surface Antigen: A Powerful Vaccine Technology for the Delivery of Disease-Associated Foreign Antigens

, 3(3): 226 - 234

Scott Thomson, Oscar Haigh, Allan Gould and Robert Tindle


DOI: 10.2174/157488508785747844




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science